default author photo

Kangsheng Gu

Anhui Medical University

SCHOLARLY PAPERS

3

DOWNLOADS

243

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Epidemiology, Prevention, and Treatment of Chemotherapy-Induced Myelosuppression in China: A National Cross-Sectional Study

Number of pages: 29 Posted: 04 Jan 2024
Nanjing Medical University - Jiangsu Cancer Hospital, Nanjing Medical University - Jiangsu Cancer Hospital, Southern Medical University - Department of Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Xuzhou Medical University - Affiliated Hospital, Qingdao University - Affiliated Hospital, Hebei Medical University - Fourth Hospital, Chinese Academy of Sciences (CAS) - Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Zhengzhou University - Henan Provincial People's Hospital, Xi'an Jiaotong University (XJTU), Second Affiliated Hospital, Peking University - Peking University Cancer Hospital & Institute, Peking University International Hospital, Jilin Cancer Hospital, Zhengzhou University, Shanghai Jiao Tong University (SJTU) - Department of Oncology, Anhui Medical University, Huazhong University of Science and Technology - Cancer Center, Tianjin Medical University - Tianjin Medical University Cancer Institute and Hospital, Shanxi Bethune Hospital, Harbin Medical University, Cancer Hospital, Department of Internal Medicine, Harbin Medical University, Cancer Hospital, Department of Internal Medicine, Fujian Medical University - Department of Thoracic Oncology, Guangxi Medical University - First Affiliated Hospital, University of Electronic Science and Technology of China (UESTC) - Sichuan Provincial People’s Hospital, Jiangxi Cancer Hospital, Hainan Cancer Hospital, Xinjiang Medical University - Affiliated Cancer Hospital, Kunming Medical University - Third Affifiliated Hospital, Nanjing Medical University - Jiangsu Cancer Hospital, Nanjing Medical University - Jiangsu Cancer Hospital, Nanjing Medical University - Jiangsu Cancer Hospital, Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Nanjing Medical University - Jiangsu Cancer Hospital
Downloads 122 (592,433)

Abstract:

Loading...

Chemotherapy, Myelosuppression, Epidemiology, Prevention, Treatment, Cross-Sectional

2.

A Predictive Model for Patients with Local-Regionally Advanced Oropharyngeal Squamous Cell Carcinoma Treated after Cervical Lymph Node Dissection

Number of pages: 15 Posted: 22 May 2023
Xiaoque Xie, Mei Kang and Kangsheng Gu
Anhui Medical University, Anhui Medical University and Anhui Medical University
Downloads 68 (899,324)

Abstract:

Loading...

OPSCC, nomogram, ELN, LNR, LODDS, PORT, SEER

3.

Efficacy and Safety of Envafolimab, Suvemcitug and Docetaxel in Patients with Previously Treated Non-Small Cell Lung Cancer: An Open-Label Phase Ii Clinical Trial

Number of pages: 24 Posted: 10 Jan 2025
Jilin Cancer Hospital - Department of Oncology, Jilin Cancer Hospital, Zhengzhou University - Henan Provincial People's Hospital, Shandong Provincial Cancer Hospital, affiliation not provided to SSRN, The First Affiliated Hospital of Zhengzhou University, affiliation not provided to SSRN, Anhui Medical University, affiliation not provided to SSRN, Anhui Provincial Cancer Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 53 (1,041,696)

Abstract:

Loading...

Non-small cell lung cancer, Suvemcitug, Anti-angiogenesis, Envafolimab, immune checkpoint inhibitor